Emapalumab-lzsg and NovoLog PenFill
Determining the interaction of Emapalumab-lzsg and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emapalumab
Brand name: Gamifant
Synonyms: Emapalumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emapalumab-lzsg-Novoseven
- Emapalumab-lzsg-NovoSeven RT
- Emapalumab-lzsg-NovoSeven RT with MixPro injection
- Emapalumab-lzsg-Novothyrox
- Emapalumab-lzsg-Noxafil
- Emapalumab-lzsg-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Embeda
- NovoLog PenFill-Embeline
- NovoLog PenFill-Embeline (Clobetasol Cream, Gel, and Ointment)
- NovoLog PenFill-Embeline (Clobetasol Solution)
- NovoLog PenFill-Embeline E
- NovoLog PenFill-Embeline Scalp Application